BY AND AMONGHolders Agreement • May 7th, 2004 • Erico Products Inc • Delaware
ev3 LLC HOLDERS AGREEMENTHolders Agreement • April 5th, 2005 • Ev3 Inc. • Delaware
WHEREAS, the Preferred Investors and the Management Investors have, pursuant to the terms of a Contribution and Exchange Agreement, dated as of August 29, 2003, by and among ev3 Acquisition Corp., a Delaware corporation ("Newco"), the Preferred Investors and the Management Investors (the "Newco Contribution Agreement"), contributed to Newco, the shares of common stock, par value $0.01 per share, of ev3 Inc., a Delaware corporation ("ev3"), the shares of Series A Convertible Preferred Stock, par value $0.01 per share, of ev3 ("Series A Preferred"), the shares of Series B Convertible Preferred Stock, par value $0,01 per share, of ev3 ("Series B Preferred") and the shares of Series C Convertible Preferred Stock, par value $0.01 per share, of ev3 ("Series C Preferred" and, together with the Series A Preferred and Series B Preferred, the "Preferred Stock") owned by each of the Preferred Investors and the Management Investors in exchange for shares of common stock, par value $0.01 per share,
KBZ CARD HOLDER’S AGREEMENTHolder’s Agreement • February 24th, 2022
Kanbawza Bank Limited (KBZ Bank) requires that all persons accessing KBZ Bank’s Card adhere to set forth the following Terms and Conditions. By requesting or using Card of KBZ Bank or permitting someone else to use these on behalf of the Cardholder, the Cardholder indicate their acknowledgment and acceptance of these Terms and Conditions, which are from time to time subject to changes.
EXHIBIT 4.4 EQUITY REGISTRATION RIGHTS JOINDER AGREEMENTHolders Agreement • May 15th, 2000 • Fibernet Telecom Group Inc\ • Telephone communications (no radiotelephone) • New York
YU-CARD HOLDER’S AGREEMENTHolder’s Agreement • September 11th, 2015
This Agreement and York University’s policies, procedures, guidelines and regulations govern the YU-card. By applying for and accepting the YU-card, you and the University agree to the following:
Confidential Treatment Requested by HedgePath Pharmaceuticals, Inc., IRS Employer Identification No. 30-0793665Holders Agreement • March 7th, 2019 • HedgePath Pharmaceuticals, Inc. • Services-commercial physical & biological research • Delaware
A Mayne Pharma International Pty Ltd, a company incorporated in Australia (ACN 007 870 984) (MPI) and HPPI entered into that certain Supply and License Agreement dated on or about September 3, 2013 (the “Original Agreement”).
HOLDER’S AGREEMENTHolder’s Agreement • June 22nd, 2007 • Freescale Semiconductor Holdings I, Ltd. • Semiconductors & related devices • Delaware
This Holder’s Agreement is made and entered into as of the date set forth next to the signature of the Holder on page 8 hereof.
